+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

"We are the heroes because we are ready to die for this country": Participants' decision-making and grounded ethics in an Ebola vaccine clinical trial



"We are the heroes because we are ready to die for this country": Participants' decision-making and grounded ethics in an Ebola vaccine clinical trial



Social Science and Medicine 203: 35-42



The 2014-2016 Ebola epidemic presented a challenging setting in which to carry out clinical trials. This paper reports findings from social science research carried out in Kambia, Northern Sierra Leone during first year of an Ebola vaccine trial (August 2015-July 2016). The social science team collected data through ethnographic observation, 42 in depth interviews; 4 life narratives; 200 exit interviews; 31 key informant interviews; and 8 focus group discussions with trial participants and community members not enrolled in the trial. Whilst research often focuses on why people refuse vaccination, we instead explore participant motivations for volunteering for the study, in spite of prevailing anxieties, rumours and mistrust during and after the Ebola outbreak. In so doing the paper contributes to on-going debates about research ethics and community engagement in resource poor contexts, offering reflections from an emergency and post-epidemic setting. We analyse participants' perceptions of the risks and benefits of participations, highlighting the importance of a contextual approach. We focus on four types of motivation: altruism; curiosity and hope; health-seeking; and notions of exchange, and argue for the role of social science in developing grounded research ethics and community engagement strategies that can take into account context and local realities.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056847183

Download citation: RISBibTeXText

PMID: 29544144

DOI: 10.1016/j.socscimed.2018.03.008


Related references

We are the heroes because we are ready to die for this country: Participants' decision-making and grounded ethics in an Ebola vaccine clinical trial. Social Science & Medicine 203: 35-42, 2018

Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola. Journal of Infectious Diseases 217(Suppl_1): S33-S39, 2018

EBOVAC-Salone: Lessons learned from implementing an Ebola vaccine trial in an Ebola-affected country. Clinical Trials 15(5): 436-443, 2018

A review of strategies used to retain participants in clinical research during an infectious disease outbreak: The PREVAIL I Ebola vaccine trial experience. Contemporary Clinical Trials Communications 11: 50-54, 2018

Attitudes towards clinical research among cancer trial participants and non-participants: an interview study using a Grounded Theory approach. Journal of Medical Ethics 33(4): 234-240, 2007

Attitudes towards Clinical Research among Cancer Trial Participants and Non-Participants: An Interview Study Using a Grounded Theory Approach. Journal of Medical Ethics 33(4): 234-240, 2007

Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak: Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola. Journal of Infectious Diseases 217(Suppl_1): S16-S23, 2018

Ethics of involving children in health-related research: applying a decision-making framework to a clinical trial. PhysioTherapy Canada. Physiotherapie Canada 62(4): 338-346, 2010

Utilizing Nurses to Staff an Ebola Vaccine Clinical Trial in Sierra Leone during the Ebola Outbreak. Journal of Infectious Diseases 217(Suppl_1): S60-S64, 2018

Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges. Clinical Trials 13(1): 49-56, 2016

Vaccine Impact Data Should Support Country Decision Making. Journal of Infectious Diseases 215(11): 1634-1636, 2017

The Guinea Phase III Ebola Vaccine Trial: Lessons for Research Ethics Review in Public Health Emergencies. Irb 39(2): 1, 2018

The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak. Journal of Infectious Diseases 217(Suppl_1): S6, 2018

Clinical ethics and the dynamics of group decision-making: applying the psychological data to decisions made by ethics committees. Hec Forum 21(2): 207-228, 2009

Ebola vaccines: keep the clinical trial protocols on the shelf and ready to roll out. Lancet 385(9980): 1913-1915, 2015